Literature DB >> 8989516

Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia.

Q Yu1, B P Toole.   

Abstract

CD44 is a widely distributed cell surface glycoprotein that is expressed as many isoforms arising from a single gene by alternative splicing. An important ligand for the widespread CD44 isoform, CD44s (standard form of CD44), is hyaluronan but ligands for the numerous variant isoforms are not as well characterized. Although it has been documented that CD44 is present at critical sites and stages of morphogenesis of several organs, the nature of the isoforms expressed and their precise localization have not been described. In this study we have determined the identity and distribution of CD44 isoforms expressed during development of several embryonic mouse organs by a combination of immunohistochemistry, in situ hybridization, reverse transcription-polymerase chain reaction, and DNA sequencing. As expected from previous studies, numerous CD44 variants are expressed by actively proliferating and invaginating epithelia at sites of epithelial-mesenchymal interaction, e.g., in the developing tooth, nose and hair follicle. Our results show that most prominent amongst these variants at these sites are CD44(v3-v10), CD44(v4-v10), and CD44(v6-v10), as was also found previously in the apical ectodermal ridge of the developing limb (Yu et al. [1996]). The common pattern of expression of these three particular variants in active epithelia implies that they play an important role in morphogenesis. Also very prominent in morphogenetically active epithelia is CD44s; hyaluronan is uniformly absent from these epithelia and often also from associated mesenchyme with which they interact, supporting the previously documented role of CD44s in endocytic removal of hyaluronan.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989516     DOI: 10.1002/(SICI)1097-0177(199701)208:1<1::AID-AJA1>3.0.CO;2-M

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  7 in total

Review 1.  The normal structure and function of CD44 and its role in neoplasia.

Authors:  R J Sneath; D C Mangham
Journal:  Mol Pathol       Date:  1998-08

2.  CD44 functions in Wnt signaling by regulating LRP6 localization and activation.

Authors:  M Schmitt; M Metzger; D Gradl; G Davidson; V Orian-Rousseau
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

3.  CD44 is a marker for the outer pillar cells in the early postnatal mouse inner ear.

Authors:  Ronna Hertzano; Chandrakala Puligilla; Siaw-Lin Chan; Caroline Timothy; Didier A Depireux; Zubair Ahmed; Jeffrey Wolf; David J Eisenman; Thomas B Friedman; Sheikh Riazuddin; Matthew W Kelley; Scott E Strome
Journal:  J Assoc Res Otolaryngol       Date:  2010-04-13

4.  Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression.

Authors:  Hisamitsu Ide; David B Seligson; Sanaz Memarzadeh; Li Xin; Steve Horvath; Purnima Dubey; Maryann B Flick; Barry M Kacinski; Aarno Palotie; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

5.  Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Authors:  Jacob Osterbur; Leslee Sprague; Maria Muccioli; Michelle Pate; Kristen Mansfield; John McGinty; Yihan Li; Yandi Li; Venktesh Shirure; Maria Cecilia Courreges; Fabian Benencia
Journal:  Immunobiology       Date:  2012-02-27       Impact factor: 3.144

6.  A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth.

Authors:  L Sherman; D Wainwright; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  1998-04-01       Impact factor: 11.361

7.  Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.

Authors:  Pi-Ling Chang; Yu-Hua Hsieh; Chao-Cheng Wang; M Margaret Juliana; Yuko Tsuruta; Laura Timares; Craig Elmets; Kang-Jey Ho
Journal:  J Dermatol Sci       Date:  2014-05-21       Impact factor: 4.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.